Drug Profile
Research programme: botulinum toxin vaccine - Soligenix
Alternative Names: BT-VACCLatest Information Update: 05 May 2011
Price :
$50
*
At a glance
- Originator Thomas Jefferson University
- Developer Soligenix
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Botulism